JME Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (2004) 33 511-522    DOI: 10.1677/jme.1.01535
© 2004 Society for Endocrinology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, J
Right arrow Articles by Voutilainen, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, J
Right arrow Articles by Voutilainen, R

cAMP-dependent protein kinase activation inhibits proliferation and enhances apoptotic effect of tumor necrosis factor-{alpha} in NCI-H295R adrenocortical cells

J Liu1, X-D Li2, A Ora1, P Heikkilä1, A Vaheri2 and R Voutilainen1,3

1 Departments of Pathology and
2 Virology, Haartman Institute, University of Helsinki, Helsinki, Finland
3 Department of Pediatrics, Kuopio University and University Hospital, Kuopio, Finland

(Requests for offprints should be addressed to J Liu, Department of Pathology, Haartman Institute, P.O. Box 21, University of Helsinki, FIN-00014 Helsinki, Finland; Email: Jiangi.Liu{at}helsinki.fi)

(J Liu and X-D Li contributed equally to this work)

Adrenocorticotropin is the major regulator of adrenocortical development and function. It acts mainly through the cAMP-dependent protein kinase A (PKA) pathway. Our aim was to study the interaction of tumor necrosis factor-{alpha} (TNF{alpha}) and the PKA pathway in adrenocortical cell proliferation and apoptosis. The PKA activator Dibutyryl cAMP ((Bu)2cAMP) strongly induced differentiation and inhibited proliferation in the human adrenocortical cell line NCI-H295R (H295R). TNF{alpha} induced apoptosis of H295R cells. Interestingly, (Bu)2cAMP treatment clearly enhanced TNF{alpha}-induced apoptosis in H295R cells, but not in another human adrenocortical cell line SW-13, the mouse adrenocortical Y-1 cell line or the human HeLa cell line. This synergistic effect was not due to the (Bu)2cAMP-induced glucocorticoid secretion since dexamethasone had no significant effect on the TNF{alpha}-induced apoptosis. (Bu)2cAMP treatment rapidly increased the expression of the proto-oncogene c-myc in H295R cells, but not in SW-13, Y-1 or HeLa cells. In transient c-myc transfection assay, c-myc expression associated with decreased expression of the proliferation marker Ki-67 in H295R cells. In conclusion, cAMP-dependent protein kinase activation reduced proliferation and augmented TNF{alpha}-induced apoptosis in adrenocortical H295R cells, and these effects were associated with increased c-myc expression.




This article has been cited by other articles:


Home page
EndocrinologyHome page
I. V. Mikhaylova, T. Kuulasmaa, J. Jaaskelainen, and R. Voutilainen
Tumor Necrosis Factor-{alpha} Regulates Steroidogenesis, Apoptosis, and Cell Viability in the Human Adrenocortical Cell Line NCI-H295R
Endocrinology, January 1, 2007; 148(1): 386 - 392.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. S. Kirschner
Emerging Treatment Strategies for Adrenocortical Carcinoma: A New Hope
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 14 - 21.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Endocrinology.